V. Rosery

Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy

M. Schuler, K. Schmid, H. Reis, 2022, Journal of Cancer Research and Clinical Oncology.

A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma

S. Ting, M. Wiesweg, B. Schumacher, 2022, Journal of Cancer Research and Clinical Oncology.

Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis

N. Reinmuth, C. Waller, M. Sebastian, 2022, Therapeutic advances in medical oncology.

Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer

M. Wiesweg, T. Herold, B. Schumacher, 2023, ESMO open.

Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols

S. Ting, M. Wiesweg, B. Schumacher, 2023, Oncology Research and Treatment.

Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy

M. Schuler, K. Schmid, H. Reis, 2022, Journal of Cancer Research and Clinical Oncology.

Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting

M. Wiesweg, M. Goetz, T. Herold, 2023, Journal of Cancer Research and Clinical Oncology.

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

A. Atmaca, J. Stratmann, N. Frost, 2023, Frontiers in oncology.